Spinal Stenosis LumbarMELD-1NCT07045714
Bilateral Lumbar Decompression Via Uniportal Endoscopic Laminotomy in Patients With Lumbar Spinal Stenosis: Multicentric Case Series
An observational study of Spinal Stenosis Lumbar, run by TecSalud Investigación Clínica at 1 site in Mexico.
Trial summary
Lumbar spinal stenosis is a condition that can cause pain, sensory disturbances, and motor deficits due to the compression of neural structures in the lumbar spine. While conservative treatments such as physical therapy and pain management can help some patients, others with persistent neurological deficits may… Read more about this study
- Who is it for?
- Ages 18 to 74 years
- Conditions the study is for
- Spinal Stenosis Lumbar
- What is being tested?
- Unilateral Laminotomy with Bilateral Lumbar Decompression (ULBLD)
- Type of treatment
- Surgery or procedure
- How many people
- 78 participants
- Where
- 1 siteMexico
- Study dates
- 25 Feb 2026to Jul 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 74 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients with lumbar spinal stenosis who continue to experience symptoms despite receiving complete conservative management for at least 3 months and who have chosen to undergo ULBLD using endoscopic uniportal technique will be recruited consecutively. Recruitment will take place at the following healthcare centers: * Centro Médico Zambrano-Hellion, TecSalud (San Pedro Garza García, N.L.) and Clínica Cuauhtémoc y Famosa (Monterrey, N.L.). Patients will be recruited by Dr. Mario Benvenutti Regato, a neurosurgery specialist with over 7 years of experience performing endoscopic spine surgery. * Centro Médico Nacional Siglo XXI (Mexico City)Patients will be recruited by Dr. Félix Domínguez Cortinas, a neurosurgery specialist with over 10 years of experience performing endoscopic spine surgery. * Hospital Ángeles Tijuana (Tijuana, B.C.)Patients will be recruited by Dr. Alfonso García Chávez, a specialist in traumatology and orthopedics with over 10 years of experience
Who may be able to join
- Provision of informed consent to participate in the study.
- Age ≥18 years and <75 years.
- Patients with lumbar spinal stenosis grade I-III according to the Lee scale.
- Radicular or myelopathic symptoms.
- Having undergone complete conservative management, including physical therapy and analgesia, for at least 3 months.
- Patients who have opted for ULBLD using endoscopic uniportal technique for lumbar spinal stenosis.
Who cannot join
- Inability to read or write.
- Prior lumbar surgeries at the levels to be treated.
- Infectious symptoms or concomitant rheumatologic diseases.
- Criteria of lumbar vertebral instability.
- Congenital spinal malformations.
- Disc herniation at the same lumbar level to be operated on.
- Medullary hyperintensity on T2-weighted magnetic resonance imaging in the levels to be treated.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Mexico1 site, 1 recruiting
- Recruiting
Hospital Zambrano Hellion, TecSalud
San Pedro Garza García, Nuevo León, 66278
Mario Benvenutti Regato, MD, (+52) 81 8888 0675, mbenreg@tec.mx
Mario Benvenutti Regato, MD
About this study
Lumbar spinal stenosis is a condition that can cause pain, sensory disturbances, and motor deficits due to the compression of neural structures in the lumbar spine. While conservative treatments such as physical therapy and pain management can help some patients, others with persistent neurological deficits may require surgical intervention. Traditional surgical approaches, including open laminectomy, have proven effective but carry risks such as extensive muscle damage, considerable blood loss, postoperative spinal instability, and prolonged recovery times.
This study evaluates a minimally invasive surgical approach called unilateral laminotomy with bilateral lumbar decompression (ULBLD) using endoscopic uniportal technique as an alternative to traditional methods for patients with lumbar spinal stenosis. The main objective is to assess changes in neurological deficits and disability in patients with lumbar spinal stenosis following this procedure. The study will also document hospitalization duration, surgical time, blood loss, and the incidence of postoperative complications.
Read more
This multicenter, prospective case series will recruit 78 patients from three medical centers in Mexico. Participants must have symptomatic lumbar spinal stenosis that persists despite at least three months of conservative treatment. Eligible patients will undergo ULBLD using endoscopic uniportal technique, a method that allows precise nerve decompression through a small incision, minimizing damage to surrounding tissues. Standardized clinical assessment tools, including the Japanese Orthopaedic Association (JOA) scale for lumbar disease, Oswestry Disability Index (ODI), and Visual Analog Scale (VAS) for pain, will be used to evaluate outcomes at multiple time points over 12 months.
By comparing patients' preoperative and postoperative evaluations, the study aims to determine whether ULBLD using endoscopic uniportal technique effectively improves neurological function and reduces disability while maintaining a favorable safety profile. Findings from this study could lead to a more precise understanding of the impact of ULBLD on disability, pain, and health-related quality of life for patients with lumbar spinal stenosis.
Read the detailed description
Lumbar spinal stenosis is a common degenerative condition characterized by narrowing of the lumbar spinal canal, resulting in compression of nerve roots and, in some cases, the spinal cord. This narrowing can be caused by degenerative changes such as hypertrophy of the ligamentum flavum, formation of osteophytes, intervertebral disc protrusion, and thickening of the facet joints. Although its prevalence increases with age, it can affect people of different age groups. Clinically, patients present symptoms such as lumbar pain, neurogenic claudication, paresthesias, and weakness in the lower extremities, which significantly decrease their quality of life. These symptoms limit the ability to perform daily activities and reduce functional independence, affecting the general well-being of individuals.
This study investigates the use of ULBLD using endoscopic uniportal technique, a minimally invasive surgical approach that offers targeted decompression through a single small incision while minimizing tissue disruption. The primary objective of the study is to evaluate changes in neurological deficits and disability in patients with lumbar spinal stenosis following this procedure. Secondary objectives include assessing the duration of hospitalization, surgical time, blood loss, and the incidence of postoperative complications.
This multicenter, prospective case series will recruit 78 patients diagnosed with lumbar spinal stenosis at three medical institutions in Mexico. The study will be conducted over a period of 24 months, with an initial 12-month patient recruitment phase, followed by postoperative follow-up assessments at predetermined time intervals up to one year. Participants will undergo ULBLD using endoscopic uniportal technique, a method designed to preserve spinal mobility while reducing compression on the nerve roots. The procedure will be performed under general anesthesia with continuous neurophysiological monitoring, including somatosensory evoked potentials, motor evoked potentials, and continuous electromyography. Using a working-channel endoscope, surgeons will perform laminotomies to remove compressive elements such as osteophytes, hypertrophic ligaments, or herniated disc material. The technique is aimed at achieving decompression with minimal disruption to the surrounding soft tissues.
Patients must meet specific inclusion criteria, including an age range of 18 to 75 years, confirmed diagnosis of lumbar spinal stenosis (Lee classification grade I-III), and the presence of neurological symptoms unresponsive to at least three months of conservative management. Exclusion criteria include prior lumbar surgery at the affected level, active infections, systemic inflammatory diseases, vertebral instability, congenital spinal malformations, and contraindications for general anesthesia.
Patient outcomes will be systematically evaluated using validated clinical assessment tools, including:
- Japanese Orthopaedic Association (JOA) Scale for lumbar disease to assess neurological function and functional status.
- Oswestry Disability Index (ODI) to measure the impact of lumbar pain on daily activities.
- Visual Analog Scale (VAS) for pain to quantify lumbar and lower limb pain intensity.
- EQ-5D-5L health-related quality of life questionnaire to evaluate overall well-being.
- Modified MacNab Criteria to determine patient satisfaction with surgical outcomes.
Descriptive statistical methods will be used to analyze demographic and clinical characteristics of the study population. Changes in primary and secondary outcomes will be evaluated using paired ttests for continuous variables and Chi-square tests for categorical variables. The impact of the procedure on neurological function and pain relief will be assessed through longitudinal comparisons between baseline and follow-up assessments at 1, 3, 6, and 12 months postoperatively. The incidence of complications will be categorized using the Clavien-Dindo classification, and the Comprehensive Complication Index will be used to quantify cumulative morbidity.
This study complies with the Declaration of Helsinki, the International Council for Harmonisation Good Clinical Practice (ICH-GCP) guidelines, and national regulatory requirements. All participants will provide written informed consent before enrollment, and patient confidentiality will be maintained through data pseudonymization. The study has been approved by the Ethics Committees of the participating institutions.
The expected impact of this study is to generate clinical evidence supporting ULBLD using endoscopic uniportal technique as a safe and effective alternative to traditional surgical approaches for lumbar spinal stenosis.
- Conditions
- Spinal Stenosis Lumbar
- Being tested
- Unilateral Laminotomy with Bilateral Lumbar Decompression (ULBLD)
- Keywords
- Lumbar Spinal Stenosis, Minimally Invasive Surgical Procedures, Endoscopic Spine Surgery, Spinal Degenerative Disease
- Medical subject headings
- Spinal Stenosis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Unilateral Laminotomy with Bilateral Lumbar Decompression (ULBLD)Procedure or surgery
Unilateral laminotomy with bilateral lumbar decompression (ULBLD) using endoscopic uniportal technique
| Study group | Role | What they receive |
|---|---|---|
| Lumbar Spinal Stenosis Cases | Patients diagnosed with lumbar spinal stenosis who exhibit persistent neurological deficits and pain despite receiving at least three months of conservative treatment. All participants have elected to undergo ULBLD using endoscopic uniportal technique. They are being prospectively followed to evaluate improvements in neurological function and reductions in pain-related disability, as well as to document perioperative outcomes including surgical time, blood loss, hospital stay, and complications. Receives: Procedure: Unilateral Laminotomy with Bilateral Lumbar Decompression (ULBLD) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Lumbar Disability (Oswestry Disability Index)
This measure assesses disability related to lumbar pain using the Oswestry Disability Index (ODI), a validated instrument scored from 0% (no disability) to 100% (maximum disability). It quantifies the impact of lumbar pain on daily activities and overall function. Changes in ODI scores over time will reflect the effectiveness of the surgical intervention in reducing pain-related disability.
Measured: Baseline; 1 month, 3 months, 6 months, and 12 months postoperatively.
Change in Neurological Function (Japanese Orthopaedic Association Score for Lumbar Disease)
This measure evaluates neurological function using the Japanese Orthopaedic Association (JOA) scale for lumbar disease. The JOA score, which ranges from -6 to 29 points (where higher scores indicate better neurological function), assesses lumbar pain, lower extremity pain and walking capacity, clinical signs, and restriction in activities of daily living. Improvements in the JOA score following surgery will be used as an indicator of enhanced neurological status.
Measured: Baseline; 1 month, 3 months, 6 months, and 12 months postoperatively.
Secondary outcomes (8)
Change in Back Pain Intensity (Visual Analog Scale - Back)
This measure assesses the intensity of back pain using the Visual Analog Scale (VAS) for back pain, a validated instrument where patients mark their level of pain on a horizontal line from 0 to 100 mm, where 0 represents "no pain" and 100 represents "worst imaginable pain". Changes in VAS-back scores over time will reflect the effectiveness of the surgical intervention in reducing back pain intensity.
Measured: Baseline; 1 month, 3 months, 6 months, and 12 months postoperatively.
Change in Lower Extremity Pain Intensity (Visual Analog Scale - Lower Extremity)
This measure assesses the intensity of lower extremity pain using the Visual Analog Scale (VAS) for lower extremity pain. Similar to VAS-back, patients mark their level of pain on a horizontal line from 0 to 100 mm, where 0 represents "no pain" and 100 represents "worst imaginable pain". This scale is particularly important for evaluating radicular symptoms commonly associated with lumbar spinal stenosis.
Measured: Baseline; 1 month, 3 months, 6 months, and 12 months postoperatively.
Health-Related Quality of Life (EQ-5D-5L)
The EQ-5D-5L questionnaire consists of two components: a descriptive system and a visual analog scale. The descriptive system comprises five dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) with five levels of problems each (no problems, slight problems, moderate problems, severe problems, extreme problems). The visual analog scale records the patient's self-rated health on a vertical scale where the endpoints are labeled 'the best health you can imagine' and 'the worst health you can imagine'. This tool has been validated for the Mexican population and allows derivation of the EQ-5D index value.
Measured: Baseline; 1 month, 3 months, 6 months, and 12 months postoperatively.
Patient Satisfaction with Surgical Outcomes (Modified MacNab Criteria)
This measure evaluates patient satisfaction with respect to functional outcomes obtained after undergoing the surgical procedure using the Modified MacNab Criteria. This scale has been widely used for decades as a tool to assess patient satisfaction and classifies outcomes as: Excellent (no pain or restriction of mobility, return to work and daily activities), Good (occasional non-radicular pain with symptom relief, able to return to work but with restrictions), Fair (some functional improvement, disability and/or inability to return to work), Poor (persists with radicular symptoms, requires new surgical intervention).
Measured: 1 month, 3 months, 6 months, and 12 months postoperatively.
Duration of Hospitalization
This metric records the total number of days from patient admission until discharge following the surgical procedure. It serves as an indicator of the immediate postoperative recovery and overall efficiency of the surgical intervention.
Measured: Measured during the index hospitalization.
Duration of Surgery
This outcome measures the surgical time, defined as the period from the initial incision to the final closure of the surgical site. It reflects procedural efficiency and may indirectly indicate the technical ease or complexity of the procedure.
Measured: Recorded intraoperatively.
Intraoperative Blood Loss
This measure quantifies the volume of blood lost during the surgical procedure, as collected via standard suction devices and measured in milliliters. It is an important indicator of surgical safety and efficiency.
Measured: Assessed during the surgical procedure.
Rate of Perioperative Complications
This measure records the incidence and severity of complications occurring during the perioperative period. Complications will be categorized according to the Clavien-Dindo classification and summarized using the Comprehensive Complication Index, providing a quantitative assessment of overall surgical morbidity.
Measured: Assessed 7 days, 1 month, 3 months, 6 months, and 12 months postoperatively.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Jul 2025
- Study start25 Feb 2026
- Primary completionJul 2027 (estimated)
- Study completionJul 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Spinal Stenosis LumbarStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 78 participants (estimated)
Sponsor and investigators
- Lead sponsor
- TecSalud Investigación Clínica
- Sponsor type
- University, hospital or other
- Collaborators
- Tecnologico de Monterrey, Centro Medico Nacional Siglo XXI IMSS, Hospital Ángeles Tijuana, Hospital Zambrano Hellion TecSalud, Mexico
- Responsible party
- Sponsor
- Investigators
- Mario Benvenutti Regato, MD, Principal investigator, TecSalud Investigación Clínica
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07045714
- Sponsor's protocol ID
- MELD-1
- Acronym
- MELD-1
- Status last verified
- Mar 2026
- First submitted
- 23 Jun 2025
- Last updated
- 4 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 4 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Bilateral Lumbar Decompression Via Uniportal Endoscopic Laminotomy in Patients With Lumbar Spinal Stenosis: Multicentric Case Series
- ClinicalTrials.gov ID
- NCT07045714
- Acronym / sponsor ID
- MELD-1 / MELD-1
- Conditions
- Spinal Stenosis Lumbar
- Keywords
- Lumbar Spinal Stenosis, Minimally Invasive Surgical Procedures, Endoscopic Spine Surgery, Spinal Degenerative Disease
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 78 participants (estimated)
- Lead sponsor
- TecSalud Investigación ClínicaUniversity, hospital or other
- Collaborators
- Tecnologico de Monterrey, Centro Medico Nacional Siglo XXI IMSS, Hospital Ángeles Tijuana, Hospital Zambrano Hellion TecSalud, Mexico
- Study start
- 25 Feb 2026 (actual)
- Primary completion
- Jul 2027 (estimated)
- Study completion
- Jul 2027 (estimated)
- First posted
- 1 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Lumbar spinal stenosis is a condition that can cause pain, sensory disturbances, and motor deficits due to the compression of neural structures in the lumbar spine. While conservative treatments such as physical therapy and pain management can help some patients, others with persistent neurological deficits may require surgical intervention. Traditional surgical approaches, including open laminectomy, have proven effective but carry risks such as extensive muscle damage, considerable blood loss, postoperative spinal instability, and prolonged recovery times.
This study evaluates a minimally invasive surgical approach called unilateral laminotomy with bilateral lumbar decompression (ULBLD) using endoscopic uniportal technique as an alternative to traditional methods for patients with lumbar spinal stenosis. The main objective is to assess changes in neurological deficits and disability in patients with lumbar spinal stenosis following this procedure. The study will also document hospitalization duration, surgical time, blood loss, and the incidence of postoperative complications.
This multicenter, prospective case series will recruit 78 patients from three medical centers in Mexico. Participants must have symptomatic lumbar spinal stenosis that persists despite at least three months of conservative treatment. Eligible patients will undergo ULBLD using endoscopic uniportal technique, a method that allows precise nerve decompression through a small incision, minimizing damage to surrounding tissues. Standardized clinical assessment tools, including the Japanese Orthopaedic Association (JOA) scale for lumbar disease, Oswestry Disability Index (ODI), and Visual Analog Scale (VAS) for pain, will be used to evaluate outcomes at multiple time points over 12 months.
By comparing patients' preoperative and postoperative evaluations, the study aims to determine whether ULBLD using endoscopic uniportal technique effectively improves neurological function and reduces disability while maintaining a favorable safety profile. Findings from this study could lead to a more precise understanding of the impact of ULBLD on disability, pain, and health-related quality of life for patients with lumbar spinal stenosis.
Detailed description
Lumbar spinal stenosis is a common degenerative condition characterized by narrowing of the lumbar spinal canal, resulting in compression of nerve roots and, in some cases, the spinal cord. This narrowing can be caused by degenerative changes such as hypertrophy of the ligamentum flavum, formation of osteophytes, intervertebral disc protrusion, and thickening of the facet joints. Although its prevalence increases with age, it can affect people of different age groups. Clinically, patients present symptoms such as lumbar pain, neurogenic claudication, paresthesias, and weakness in the lower extremities, which significantly decrease their quality of life. These symptoms limit the ability to perform daily activities and reduce functional independence, affecting the general well-being of individuals.
This study investigates the use of ULBLD using endoscopic uniportal technique, a minimally invasive surgical approach that offers targeted decompression through a single small incision while minimizing tissue disruption. The primary objective of the study is to evaluate changes in neurological deficits and disability in patients with lumbar spinal stenosis following this procedure. Secondary objectives include assessing the duration of hospitalization, surgical time, blood loss, and the incidence of postoperative complications.
This multicenter, prospective case series will recruit 78 patients diagnosed with lumbar spinal stenosis at three medical institutions in Mexico. The study will be conducted over a period of 24 months, with an initial 12-month patient recruitment phase, followed by postoperative follow-up assessments at predetermined time intervals up to one year. Participants will undergo ULBLD using endoscopic uniportal technique, a method designed to preserve spinal mobility while reducing compression on the nerve roots. The procedure will be performed under general anesthesia with continuous neurophysiological monitoring, including somatosensory evoked potentials, motor evoked potentials, and continuous electromyography. Using a working-channel endoscope, surgeons will perform laminotomies to remove compressive elements such as osteophytes, hypertrophic ligaments, or herniated disc material. The technique is aimed at achieving decompression with minimal disruption to the surrounding soft tissues.
Patients must meet specific inclusion criteria, including an age range of 18 to 75 years, confirmed diagnosis of lumbar spinal stenosis (Lee classification grade I-III), and the presence of neurological symptoms unresponsive to at least three months of conservative management. Exclusion criteria include prior lumbar surgery at the affected level, active infections, systemic inflammatory diseases, vertebral instability, congenital spinal malformations, and contraindications for general anesthesia.
Patient outcomes will be systematically evaluated using validated clinical assessment tools, including:
- Japanese Orthopaedic Association (JOA) Scale for lumbar disease to assess neurological function and functional status.
- Oswestry Disability Index (ODI) to measure the impact of lumbar pain on daily activities.
- Visual Analog Scale (VAS) for pain to quantify lumbar and lower limb pain intensity.
- EQ-5D-5L health-related quality of life questionnaire to evaluate overall well-being.
- Modified MacNab Criteria to determine patient satisfaction with surgical outcomes.
Descriptive statistical methods will be used to analyze demographic and clinical characteristics of the study population. Changes in primary and secondary outcomes will be evaluated using paired ttests for continuous variables and Chi-square tests for categorical variables. The impact of the procedure on neurological function and pain relief will be assessed through longitudinal comparisons between baseline and follow-up assessments at 1, 3, 6, and 12 months postoperatively. The incidence of complications will be categorized using the Clavien-Dindo classification, and the Comprehensive Complication Index will be used to quantify cumulative morbidity.
This study complies with the Declaration of Helsinki, the International Council for Harmonisation Good Clinical Practice (ICH-GCP) guidelines, and national regulatory requirements. All participants will provide written informed consent before enrollment, and patient confidentiality will be maintained through data pseudonymization. The study has been approved by the Ethics Committees of the participating institutions.
The expected impact of this study is to generate clinical evidence supporting ULBLD using endoscopic uniportal technique as a safe and effective alternative to traditional surgical approaches for lumbar spinal stenosis.
Study design
- Observational model
- Case only
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Lumbar Spinal Stenosis Cases | – | Procedure: Unilateral Laminotomy with Bilateral Lumbar Decompression (ULBLD)Patients diagnosed with lumbar spinal stenosis who exhibit persistent neurological deficits and pain despite receiving at least three months of conservative treatment. All participants have elected to undergo ULBLD using endoscopic uniportal technique. They are being prospectively followed to evaluate improvements in neurological function and reductions in pain-related disability, as well as to document perioperative outcomes including surgical time, blood loss, hospital stay, and complications. |
Who may qualify
- Ages
- 18 to 74 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients with lumbar spinal stenosis who continue to experience symptoms despite receiving complete conservative management for at least 3 months and who have chosen to undergo ULBLD using endoscopic uniportal technique will be recruited consecutively. Recruitment will take place at the following healthcare centers: * Centro Médico Zambrano-Hellion, TecSalud (San Pedro Garza García, N.L.) and Clínica Cuauhtémoc y Famosa (Monterrey, N.L.). Patients will be recruited by Dr. Mario Benvenutti Regato, a neurosurgery specialist with over 7 years of experience performing endoscopic spine surgery. * Centro Médico Nacional Siglo XXI (Mexico City)Patients will be recruited by Dr. Félix Domínguez Cortinas, a neurosurgery specialist with over 10 years of experience performing endoscopic spine surgery. * Hospital Ángeles Tijuana (Tijuana, B.C.)Patients will be recruited by Dr. Alfonso García Chávez, a specialist in traumatology and orthopedics with over 10 years of experience
Key inclusion criteria (6 listed)
- Provision of informed consent to participate in the study.
- Age ≥18 years and <75 years.
- Patients with lumbar spinal stenosis grade I-III according to the Lee scale.
- Radicular or myelopathic symptoms.
- Having undergone complete conservative management, including physical therapy and analgesia, for at least 3 months.
Key exclusion criteria (7 listed)
- Inability to read or write.
- Prior lumbar surgeries at the levels to be treated.
- Infectious symptoms or concomitant rheumatologic diseases.
- Criteria of lumbar vertebral instability.
- Congenital spinal malformations.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Unilateral Laminotomy with Bilateral Lumbar Decompression (ULBLD)Unilateral laminotomy with bilateral lumbar decompression (ULBLD) using endoscopic uniportal technique | Procedure or surgery | Lumbar Spinal Stenosis Cases |
Primary outcome
Change in Lumbar Disability (Oswestry Disability Index)
Time frame: Baseline; 1 month, 3 months, 6 months, and 12 months postoperatively.
This measure assesses disability related to lumbar pain using the Oswestry Disability Index (ODI), a validated instrument scored from 0% (no disability) to 100% (maximum disability). It quantifies the impact of lumbar pain on daily activities and overall function. Changes in ODI scores over time will reflect the effectiveness of the surgical intervention in reducing pain-related disability.
Change in Neurological Function (Japanese Orthopaedic Association Score for Lumbar Disease)
Time frame: Baseline; 1 month, 3 months, 6 months, and 12 months postoperatively.
This measure evaluates neurological function using the Japanese Orthopaedic Association (JOA) scale for lumbar disease. The JOA score, which ranges from -6 to 29 points (where higher scores indicate better neurological function), assesses lumbar pain, lower extremity pain and walking capacity, clinical signs, and restriction in activities of daily living. Improvements in the JOA score following surgery will be used as an indicator of enhanced neurological status.
8 secondary outcomes
Change in Back Pain Intensity (Visual Analog Scale - Back)
Time frame: Baseline; 1 month, 3 months, 6 months, and 12 months postoperatively.
Change in Lower Extremity Pain Intensity (Visual Analog Scale - Lower Extremity)
Time frame: Baseline; 1 month, 3 months, 6 months, and 12 months postoperatively.
Health-Related Quality of Life (EQ-5D-5L)
Time frame: Baseline; 1 month, 3 months, 6 months, and 12 months postoperatively.
Patient Satisfaction with Surgical Outcomes (Modified MacNab Criteria)
Time frame: 1 month, 3 months, 6 months, and 12 months postoperatively.
Duration of Hospitalization
Time frame: Measured during the index hospitalization.
Duration of Surgery
Time frame: Recorded intraoperatively.
Intraoperative Blood Loss
Time frame: Assessed during the surgical procedure.
Rate of Perioperative Complications
Time frame: Assessed 7 days, 1 month, 3 months, 6 months, and 12 months postoperatively.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Mar 2026.
- Individual participant dataSharing planned: No
Related trials for Spinal Stenosis Lumbar
Not yet recruitingObservational study
Foraminal Imaging and Symptoms in Single-Level Degenerative Lumbar Stenosis
Degenerative Lumbar Spinal Stenosis, Lumbar Foraminal Stenosis
Recruiting
Post-Market Clinical Study of Functional Motion Outcomes in Subjects Treated With the Minuteman Device
Degenerative Conditions of the Lumbar Spine, Lumbar Spinal Stenosis
RecruitingObservational study
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Lumbar Spinal Stenosis
RecruitingObservational study
Thoracic-Lumbar Arthrodesis- Implanet Jazz
Spondylolisthesis, Spinal Stenosis
Recruiting
Surgical Treatment of Adjacent Segment Stenosis
Adjacent Segment Disease, Lumbar Spinal Stenosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Mario Benvenutti Regato, MD principal investigator
TecSalud Investigación Clínica
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Spinal Stenosis Lumbar, run by TecSalud Investigación Clínica at 1 site in Mexico.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 4 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Mexico. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Mario Benvenutti Regato, MD ((+52) 81 8888 0675, mbenreg@tec.mx), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Lumbar Disability (Oswestry Disability Index) (time frame: Baseline; 1 month, 3 months, 6 months, and 12 months postoperatively.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Mar 2026.